Glazer Capital LLC’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-390,098
Closed -$4.63M – 258
2025
Q1
$4.63M Sell
390,098
-5,284
-1% -$62.1K 0.21% 70
2024
Q4
$4.61M Sell
395,382
-2,366
-0.6% -$27.4K 0.31% 49
2024
Q3
$4.56M Sell
397,748
-5,043
-1% -$57.4K 0.27% 48
2024
Q2
$4.54M Sell
402,791
-7,309
-2% -$82K 0.35% 56
2024
Q1
$4.56M Sell
410,100
-6,782
-2% -$74.9K 0.47% 50
2023
Q4
$4.57M Buy
416,882
+76,475
+22% +$832K 0.47% 53
2023
Q3
$3.68M Sell
340,407
-13,406
-4% -$144K 0.24% 72
2023
Q2
$3.77M Buy
353,813
+262,420
+287% +$2.78M 0.25% 82
2023
Q1
$959K Hold
91,393
– – 0.05% 200
2022
Q4
$937K Buy
+91,393
New +$927K 0.02% 283

Other funds holding RENE

Glazer Capital LLC's RENE Position: Q2 2025 in Review

Glazer Capital LLC sold out of Cartesian Growth Corp II (RENE) in Q2 2025, closing a stake of 390,098 shares — an estimated $4.63M sold.

Glazer Capital LLC first reported a position in RENE in Q4 2022 and held it in 10 quarters. The position peaked at $4.63M in Q1 2025. 4 funds tracked by Wall St. Rank hold RENE as of Q2 2025.

  • Glazer Capital LLC reported no remaining Cartesian Growth Corp II position as of Q2 2025 after selling out during the quarter.
  • Glazer Capital LLC sold 390,098 Cartesian Growth Corp II shares in Q2 2025, an estimated $4.63M.
  • Glazer Capital LLC first reported a position in Cartesian Growth Corp II in Q4 2022 and held it in 10 quarters.
  • Glazer Capital LLC's Cartesian Growth Corp II position peaked at $4.63M in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q2 2025.

Based on Glazer Capital LLC's 13F filing for Q2 2025, filed 14 Aug 2025.